The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
News the HIV world has been waiting for – long-acting injectable cabotegravir (CAB-LA) is a potentially game-changing tool to prevent HIV in women.
Ending paediatric AIDS is now within our reach thanks to the mass scale-up of prevention of mother-to-child transmission (PMTCT) services. However, the treatment needs for children already living with HIV must to be urgently addressed.
New HIV infections among adolescent girls and young women fell by only 6% between 2010 and 2015. This puts the HIV response severely off-track to reach the UNAIDS 2020 Fast-Track Targets.